Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17893795 | 0.83 | MEN1 (0.41) | L3MBTL1KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL17899961 | 0.82 | L3MBTL1 (0.37) | L3MBTL1KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL17900016 | 0.80 | L3MBTL1 (0.33) | L3MBTL1KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL17899967 | 0.80 | MAPT (0.41) | L3MBTL1KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL17899912 | 0.78 | — | — | |
| SCHEMBL17899984 | 0.77 | ADAMTS5 (0.33) | L3MBTL1KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL17899963 | 0.77 | MCL1 (0.33) | KCNA3 | |
| SCHEMBL17899968 | 0.77 | MEN1 (0.38) | L3MBTL1KDM4EALDH1A1CYP1A2MAPT | |
| SCHEMBL105042 | 0.74 | MEN1 (0.46) | L3MBTL1KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL15975338 | 0.72 | MEN1 (0.47) | L3MBTL1KDM4EALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10329483-B2 | Fluorene derivatives as light emitting elements for electroluminescent devices | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-06-25 | — | — | US | disclosed |
| US-20180002597-A1 | Fluorene Derivatives as Light Emitting Elements for Electroluminescent Devices | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2018-01-04 | — | — | US | disclosed |
| WO-2016109274-A1 | FLUORENE DERIVATIVES AS LIGHT EMITTING ELEMENTS FOR ELECTROLUMINESCENT DEVICES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10329483-B2 | Fluorene derivatives as light emitting elements for electroluminescent devices | LEF1, AFF2, CELF2 | KCNA3 110/4885L3MBTL1 1076/4885KDM4E 3225/4885 |
| US-20180002597-A1 | Fluorene Derivatives as Light Emitting Elements for Electroluminescent Devices | LEF1, AFF2, CELF2 | KCNA3 110/4885L3MBTL1 1076/4885KDM4E 3225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.